With U.S. COVID-19 cases rising again, health officials said they are considering making second booster shots available to people under the age of 50. In March, the Food and Drug Administration authorized a second booster shots for older people. (Reuters)

The Centers for Disease Control and Prevention warned about a monkeypox outbreak in the U.K. “We do have a level of concern that this is very different than what we typically think of from monkeypox,” senior CDC official Jennifer McQuiston told STAT. “We have some concern that there could be spread outside the U.K. associated with this.” (STAT)

Remix Therapeutics announced $70 million in new financing to develop its RNA processing tech. The additional funding followed a deal with Johnson & Johnson a few months ago that could be worth up to $1 billion. (Endpoints News)

Investors in mental health startup Cerebral called for the company’s founder and CEO, Kyle Robertson, to be dismissed. The company is under federal investigation into its drug prescribing practices and announced Monday that its providers would not prescribe most controlled substances anymore. (Bloomberg)

House Democrats said they will hold hearings on the baby formula shortage and possibly develop legislation that would boost Food and Drug Administration inspection staff. “Those [baby formula] facilities have to be inspected,” Rep. Rosa DeLauro said. “FDA does not have the adequate inspection force to be able to do that and to do it in a timely way.” (CNBC)